Clinical trials
Colitis, Ulcerative trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Active, not recruiting | 8 |
| Recruiting | 7 |
| Unknown status | 5 |
| Terminated | 4 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 7 |
| Janssen Research & Development, LLC | 6 |
| Pfizer | 4 |
| Region Skane | 4 |
| InDex Pharmaceuticals | 3 |
| Sahlgrenska University Hospital | 3 |
| Takeda | 3 |
| Ferring Pharmaceuticals | 2 |
| GlaxoSmithKline | 2 |
| Region Stockholm | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 61 |
| Inflammatory Bowel Diseases | 15 |
| Crohn Disease | 8 |
| Gastrointestinal Diseases | 3 |
| Pouchitis | 2 |
| Adenomatous Polyposis Coli | 1 |
| Cholangitis, Sclerosing | 1 |
| Colitis | 1 |
| Colorectal Neoplasms | 1 |
| Communicable Diseases | 1 |
Trials
Showing 51 to 61 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.